Drug
Metformin 500 mg
Metformin 500 mg is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
Ph phase_3
1
33%
Ph phase_1
1
33%
Ph phase_4
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (33.3%)
Phase 31 (33.3%)
Phase 41 (33.3%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_3
Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)
NCT01076088
completedphase_4
Adjunctive Low-dose Metformin in Patients With Schizophrenia and Metabolic Abnormalities
NCT02751307
completedphase_1
Bioequivalence Study in Healthy Volunteers for Empagliflozin/Metformin Fixed Dose Combination Compared to Separate Tablets
NCT02028767
Clinical Trials (3)
Showing 3 of 3 trials
NCT01076088Phase 3
Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)
NCT02751307Phase 4
Adjunctive Low-dose Metformin in Patients With Schizophrenia and Metabolic Abnormalities
NCT02028767Phase 1
Bioequivalence Study in Healthy Volunteers for Empagliflozin/Metformin Fixed Dose Combination Compared to Separate Tablets
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3